By /

Professor PhD. Laura Mazilu

Contact details​

E-mail: 

Curriculum Vitae

Vezi CV

Main research areas:

  • Thoracic Oncology: Biomarkers and Targeted Therapies/Immunotherapy (NSCLC/SCLC).​
  • Breast Cancer (Early-Stage and Metastatic): Optimization of treatment and motioning of toxicities (e.g., CDK4/6).​
  • Cardio-oncology: cardiovascular risk and complications of oncologic treatments.
  • Registries & real-world data (RWD/RWE) in oncology (e.g., EuMelaReg – melanoma).
  • Multicenter clinical research (clinical/observational studies) and implementation of guidelines/protocols in oncology.

Projects:

  • ESOGENSCAN – corelarea manifestărilor clinice, paraclinice și morfopatologice cu modificările genomice în cancerul esofagian scuamos (membru echipă).​

  • Learn, share, live better! – proiect internațional Bristol-Myers Squibb Foundation pentru educația și suportul pacienților oncologici (responsabil de proiect România).​

  • AR‑v7 – implicații clinice în cancerul de prostată avansat – grant intern UOC, director de proiect, axat pe biomarkeri de rezistență la tratament.​

Key publications:

  1. Mazilu, L., Katsiki, N., Nikolouzakis, T. K., Aslanidis, M. I., Lazopoulos, G., Kouretas, D., Tsatsakis, A., Suceveanu, A.-I., Pantea-Stoian, A., Parepa, I.-R., Voinea, F., Suceveanu, A. P., Arsene, A. L., Velescu, B. Ș., Vesa, C., & Nitipir, C. (2021). Thrombosis and haemostasis challenges in COVID‐19: Therapeutic perspectives of heparin and tissue‐type plasminogen activator and potential toxicological reactions—A mini‐review. Food and Chemical Toxicology, 148, 111974. https://doi.org/10.1016/j.fct.2021.111974​

  2. Mazilu, L., Suceveanu, A. I., Gheorghe, A. D., Voinea, F., Suceveanu, A. P., Pituru, S., Diaconu, C. C., Parepa, I. R., Pantea-Stoian, A., Pop, C. S., & Suceveanu, A. I. (2019). Incidence of chemotherapy-induced peripheral neuropathy in cancer patients in clinical practice. Farmacia, 67(3), 472–476. ​

  3. Mazilu, L., Stanculeanu, D. L., Gheorghe, A. D., Suceveanu, A. P., Parepa, I. R., Pantea-Stoian, A., & Suceveanu, A. I. (2019). Clinical impact of association between diabetes and lung cancer. Revista de Chimie (Bucharest), 70(4), 1149–1151. ​

  4. Mazilu, L., Stanculeanu, D. L., Gheorghe, A. D., Suceveanu, A. P., Parepa, I. R., Pantea-Stoian, A., Pop, C. S., Bratu, O., & Suceveanu, A. I. (2019). Chemotherapy and other factors affecting quality of life in non-small cell lung cancer (NSCLC) patients. Revista de Chimie (Bucharest), 70(1), 33–35. ​

  5. Mazilu, L., Stanculeanu, D. L., Gheorghe, A. D., Suceveanu, A. P., Hainarosie, R., Parepa, I. R., Bratu, O., Diaconu, C. C., Manuc, D., Pantea Stoian, A., & Suceveanu, A. I. (2018). Specific adverse effects of bevacizumab in the treatment of non-squamous non-small cell lung cancer (NSCLC) in clinical practice. Revista de Chimie (Bucharest), 69(12), 3644–3647. ​